Quangen Gao Selected Research

lupeol

10/2021	Retraction Note to: Lupeol enhances inhibitory effect of 5-fluorouracil on human gastric carcinoma cells.
8/2021	Retraction Note to: Lupeol inhibits proliferation and induces apoptosis of human pancreatic cancer PCNA-1 cells through AKT/ERK pathways.
12/2016	Lupeol Induces Apoptosis and Cell Cycle Arrest of Human Osteosarcoma Cells Through PI3K/AKT/mTOR Pathway.
5/2016	Lupeol enhances inhibitory effect of 5-fluorouracil on human gastric carcinoma cells.
1/2016	Lupeol induces apoptosis and inhibits invasion in gallbladder carcinoma GBC-SD cells by suppression of EGFR/MMP-9 signaling pathway.
3/2015	Lupeol inhibits proliferation and induces apoptosis of human pancreatic cancer PCNA-1 cells through AKT/ERK pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Quangen Gao Research Topics

Disease

16	Neoplasms (Cancer) 01/2020 - 06/2014
7	Carcinoma (Carcinomatosis) 10/2021 - 01/2016
5	Hepatocellular Carcinoma (Hepatoma) 08/2018 - 11/2015
4	Pancreatic Neoplasms (Pancreatic Cancer) 09/2021 - 03/2015
4	Stomach Neoplasms (Stomach Cancer) 01/2021 - 11/2014
2	Carcinogenesis 08/2018 - 02/2018
2	Neoplasm Metastasis (Metastasis) 11/2014 - 06/2014
1	Gallbladder Neoplasms (Gallbladder Cancer) 01/2020
1	Colonic Neoplasms (Colon Cancer) 12/2016
1	Osteosarcoma (Osteogenic Sarcoma) 12/2016
1	Venous Thromboembolism 10/2016
1	Liver Diseases (Liver Disease) 01/2015
1	Fibrosis (Cirrhosis) 01/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015

Drug/Important Bio-Agent (IBA)

7	oxymatrineIBA 01/2021 - 06/2014
6	lupeolIBA 10/2021 - 03/2015
4	Fluorouracil (Carac)FDA LinkGeneric 10/2021 - 05/2016
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2016
4	TriterpenesIBA 12/2016 - 03/2015
3	MatrinesIBA 11/2015 - 06/2014
2	Gemcitabine FDA Link 09/2021 - 01/2019
2	S-Adenosylmethionine (Ademetionine)IBA 09/2021 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2018
2	Propidium (Propidium Iodide)IBA 12/2016 - 06/2016
2	Annexin A5IBA 12/2016 - 06/2016
2	Matrix Metalloproteinases (MMPs)IBA 01/2016 - 11/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	matrigelIBA 01/2020
1	bufalinIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2019
1	SurvivinIBA 08/2018
1	Transcription Factors (Transcription Factor)IBA 08/2018
1	PhytochemicalsIBA 02/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2016
1	Cyclin D1IBA 12/2016
1	TOR Serine-Threonine KinasesIBA 12/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2016
1	Methylnitronitrosoguanidine (MNNG)IBA 12/2016
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 12/2016
1	CytokinesIBA 10/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2016
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 06/2016
1	RNA (Ribonucleic Acid)IBA 06/2016
1	Caspase 3 (Caspase-3)IBA 06/2016
1	FlavonoidsIBA 05/2016
1	thiazolyl blueIBA 05/2016
1	QuercetinIBA 05/2016
1	Cytostatic AgentsIBA 01/2016
1	AlkaloidsIBA 11/2015
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 03/2015
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 01/2015

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2020 - 06/2014
3	Chemoprevention 06/2016 - 03/2015
1	Therapeutics 12/2016
1	Adjuvant Chemotherapy 05/2016
1	Induced Hyperthermia (Thermotherapy) 05/2016
1	Intravenous Administration 11/2015
1	Transplantation 11/2014
1	Radiotherapy 06/2014